Opinion Review
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 21, 2022; 28(47): 6619-6631
Published online Dec 21, 2022. doi: 10.3748/wjg.v28.i47.6619
How to avoid overtreatment of benign colorectal lesions: Rationale for an evidence-based management
Marco Bustamante-Balén
Marco Bustamante-Balén, Gastrointestinal Endoscopy Unit, Gastrointestinal Endoscopy Research Group, Hospital Universitari I Politècnic La Fe, Health Research Institute Hospital La Fe (IISLaFe), Valencia 46026, Spain
Author contributions: Bustamante-Balén M conceived the idea for the manuscript, performed the literature review, and drafted the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Marco Bustamante-Balén, MD, PhD, Doctor, Gastrointestinal Endoscopy Unit, Gastrointestinal Endoscopy Research Group, Hospital Universitari I Politècnic La Fe, Health Research Institute Hospital La Fe (IISLaFe), Avda. Fernando Abril Martorell, 106, Valencia 46026, Spain. bustamante_mar@gva.es
Received: September 13, 2022
Peer-review started: September 13, 2022
First decision: October 3, 2022
Revised: October 10, 2022
Accepted: November 27, 2022
Article in press: November 27, 2022
Published online: December 21, 2022
Core Tip

Core Tip: Despite endoscopic treatment being of choice for the treatment of large benign colorectal neoplasms, many lesions are still being referred to surgery. Problems in identifying a polyp as complex to resect, too much self-confidence of the endoscopists, and the lack of a referral pathway may be causes underlying this situation. The organization of a structured referral network may be the main step to reducing the overtreatment of benign lesions. Decisive support from Medical Societies and Public Administration is warranted to set up this paradigm change.